Kristen Pierce's most recent trade in CERo Therapeutics Holdings Inc. was a trade of 154,841 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CERo Therapeutics Holdings... | Kristen Pierce | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 154,841 | 154,841 | - | - | Stock Option (Right to Buy) | |
| CERo Therapeutics Holdings... | Kristen Pierce | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) |